Stephanie Price
Stephanie is a journalist for Business of Cannabis, writing about science, research, policy and industry developments in cannabis, CBD and psychedelics. In 2013 Stephanie gained her BA in English and Media, focusing on journalism and propaganda, where her magazine 'Game Theory' focused on developments and disruptors over the coming decade including cannabis, psychedelics, blockchain/crypto and free speech. In 2015 Stephanie received her National Council for the Training of Journalists (NCTJ) diploma whilst working as a reporter in North Wales. Stephanie has a specialism in Medical Cannabis: The Health Effects of THC and CBD through the University of Colorado, and a certificate from the Medical Cannabis Clinicians Society on "Medical Cannabis Explained".
Stephanie Price · page 48
- Policy & Regulation
Last Prisoner Project partnership to help non-violent cannabis prisoners
The new partnership with Dutchie will help to remove criminal records related to cannabis charges.
- CBD Market
Two-city outdoor CBG marketing campaign launched by Cellular Goods
Cellular Goods is running the outdoor digital campaign for the next two months.
- CBD Market
FSA gives update on Novel Foods progress
The FSA has seen hold-ups due to the volume of CBD Novel Foods applications.
- Medical
Cannabis harvest ready to be shipped for Dutch inspection
Canadian-based Xebra will be delivering its first cannabis shipment this month.
- Cultivation
Hemspan progresses with plans for hemp houses
Construction company, Hemspan, is about to break ground on its first 14 house scheme.
- Pharmaceutical
Major shareholder appeals for urgent change at Oxford Cannabinoid Technologies
The appeal states there is an urgent need to address serious governance and sclerotic management issues.
- Uncategorized
Exploring California’s cannabis supply chain
Cannabis Wealth speaks to Rob Koch, director of strategy and information at California distributor, Nabis.
- Companies
Geneva-based stock exchange launched for cannabis commodities
The CBX Stock Exchange will offer “seed to shelf” transparency.
- Pharmaceutical
Positive results for cannabinoid targeting multi-billion pain market
Oxford Cannabinoid Technologies has stated it will begin Phase I clinical trials early next year.
- CBD Market
The women in cannabis study: a living history
A new study has explored the experiences of women in the cannabis industry.
- Uncategorized
Israel calls for expungement of cannabis convictions
The call aims to remove the “stain” of criminality associated with cannabis.
- Cultivation
Cannabis and climate change environmental impacts
Canxchange explores the relationship between cannabis and climate change.
